Healthcare · Pharmaceutical expenditure
Canada's pharmaceutical expenditure reached 2 % GDP of GDP in 2026, ranking 12th among 197 countries. A large portion of this spending goes toward expensive patented drugs, with prices notably above the global average. Public drug coverage is only partial, leaving many residents to rely on private insurance or out-of-pocket payments. This dynamic makes Canada's pharmaceutical market one of the largest per capita in the world.
Data for 2026 · unit: % GDP
Position
#12 / 197
Canada world ranking
Country position on the scale from last to first place for this indicator.
CA
#12
#197#1
Trend
Change over time
Change in indicator over the available period.
1.20
1990
1.50
2000
1.70
2010
1.90
2020
2.00
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Canada stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Canada — how much?
Based on 2026 data — 2 % GDP. This is rank #12 out of 197 countries.
What is Canada's rank by Pharmaceutical expenditure?
Canada ranks #12 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Canada?
Over the available period the indicator changed from 1.20 to 2 % GDP.